ADAPT and Improvise: Overcoming Bacillus Calmette-Guerin Unresponsiveness in Non-muscle-invasive Bladder Cancer

被引：1
|
作者：
Maitre, Priyamvada [1 ]
Sangar, Vijay [2 ]
Choudhury, Ananya [1 ,3 ,4 ]
机构：
[1] Univ Manchester, Christie NHS Fdn Trust, Dept Clin Oncol, Manchester, England
[2] Univ Manchester, Christie NHS Fdn Trust, Dept Uro Oncol, Manchester, England
[3] Univ Manchester, Div Canc Sci, Manchester, England
[4] Univ Manchester, Christie NHS Fdn Trust, Dept Clin Oncol, Manchester M20 4BX, England
来源：
EUROPEAN UROLOGY | 2023年 / 83卷 / 06期
关键词：
RADIATION-THERAPY; PHASE-II; RADIOTHERAPY; TRIAL;
D O I：
10.1016/j.eururo.2023.02.018
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：495 / 496
页数：2
相关论文
共 50 条
  • [21] Bacillus Calmette-Guerin treatment of non-muscle invasive bladder cancer
    Sylvester, Richard J.
    INTERNATIONAL JOURNAL OF UROLOGY, 2011, 18 (02) : 113 - 120
  • [22] Re: Intravesical bacillus Calmette-Guerin with Interferon-Alpha versus Intravesical bacillus Calmette-Guerin for Treating Non-Muscle-Invasive Bladder Cancer Editorial Comment
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2018, 199 (03): : 608 - 609
  • [23] Evaluation of the Side Effect Profile of Intracavitary Bacillus Calmette-Guerin Treatment in Non-muscle-invasive Bladder Cancer
    Tonyali, Senol
    Karaaslan, Mustafa
    Yilmaz, Mehmet
    Ceylan, Cavit
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2018, 17 (04): : 120 - 123
  • [24] Non-muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guerin
    de Jong, Florus C.
    Laajala, Teemu D.
    Hoedemaeker, Robert F.
    Jordan, Kimberley R.
    van der Made, Angelique C. J.
    Boeve, Egbert R.
    van der Schoot, Deric K. E.
    Nieuwkamer, Bart
    Janssen, Emiel A. M.
    Mahmoudi, Tokameh
    Boormans, Joost L.
    Theodorescu, Dan
    Costello, James C.
    Zuiverloon, Tahlita C. M.
    SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (697)
  • [25] Non-muscle-invasive bladder cancer: Intravesical treatments beyond Bacille Calmette-Guerin
    Packiam, Vignesh T.
    Johnson, Scott C.
    Steinberg, Gary D.
    CANCER, 2017, 123 (03) : 390 - 400
  • [26] Bacillus Calmette-Guerin Failure in Non-muscle-invasive Bladder Cancer: One Size Does Not Fit All
    McKiernan, James
    EUROPEAN UROLOGY, 2016, 70 (05) : 786 - 787
  • [27] ROLE OF ORAL PENTOSAN POLYSULFATE IN BACILLUS CALMETTE-GUERIN THERAPY IN PATIENTS WITH NON-MUSCLE-INVASIVE BLADDER CANCER
    Hyeon, Yu Seong
    Seok, Chung Ho
    Chang, Hwang Eu
    Sun-Ouck, Kim
    Jin, Oh Kyung
    Il, Jung Seung
    Won, Kang Taek
    Dongdeuk, Kwon
    Kwangsung, Park
    JOURNAL OF UROLOGY, 2022, 207 (05): : E935 - E935
  • [28] Analysis of tolerability of intravesical bacillus Calmette-Guerin (BCG) therapy in non-muscle-invasive bladder cancer.
    Miyazaki, Jun
    Ishizuka, Naoki
    Hinotsu, Shiro
    Akaza, Hideyuki
    Nishiyama, Hiroyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [29] A retrospective study on tolerability and complications of bacillus Calmette-Guerin (BCG) instillations for non-muscle-invasive bladder cancer
    Nummi, Antti
    Jarvinen, Riikka
    Sairanen, Jukka
    Huotari, Kaisa
    SCANDINAVIAN JOURNAL OF UROLOGY, 2019, 53 (2-3) : 116 - 122
  • [30] Role of oral pentosan polysulfate in Bacillus Calmette-Guerin therapy in patients with non-muscle-invasive bladder cancer
    Lee, Ho Yeon
    Jung, Seung Il
    Lim, Do Gyeong
    Chung, Ho Seok
    Hwang, Eu Chang
    Kwon, Dong Deuk
    INVESTIGATIVE AND CLINICAL UROLOGY, 2022, 63 (05) : 539 - 545
12345